Increased STAG2 dosage defines a novel cohesinopathy with intellectual disability and behavioral problems

Raman Kumar, Mark A. Corbett, Bregje W.M. Van Bon, Alison Gardner, Joshua A.Woenig, Lachlan A. Jolly, Evelyn Douglas, Kathryn Friend, Chuan Tan, Hilde Van Esch, Maureen Holvoet, Martine Raynaud, Michael Field, Melanie Leffler, Bartlomiej Budny, Marzena Wisniewska, Magdalena Badura-Stronka, Anna Latos-Bieleńska, Jacqueline Batanian, Jill A. RosenfeldLina Basel-Vanagaite, Corinna Jensen, Melanie Bienek, Guy Froyen, Reinhard Ullmann, Hao Hu, Michael I. Love, Stefan A. Haas, Pawel Stankiewicz, Sau Wai Cheung, Anne Baxendale, Jillian Nicholl, Elizabeth M. Thompson, Eric Haan, Vera M. Kalscheuer, Jozef Gecz*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Increased STAG2 dosage defines a novel cohesinopathy with intellectual disability and behavioral problems'. Together they form a unique fingerprint.

Medicine & Life Sciences